首站-论文投稿智能助手
典型文献
Non-invasive gene delivery across the blood-brain barrier: present and future perspectives
文献摘要:
The aging of society has arrived, and is accompanied by an increase in the absolute numbers of patients with neurological disorders, such as Alzheimer's and Parkinson's diseases (Feigin et al., 2020). Such diseases, particularly Alzheimer's disease and other forms of dementia, affect not only the patients themselves, but also the people around them, including family members and care givers. As a result, such neurological disorders are thought to carry a larger social burden compared to other diseases. The most critical point in the current situation is that there is no effective treatment despite the fact that the number of patients increase with the aging of the population. Gene therapy has great promise for the treatment of neurological disorders (Sun and Roy, 2021), but delivering therapeutic genes is a major impediment for the success of gene therapy.
文献关键词:
作者姓名:
Seigo Kimura
作者机构:
Laboratory for Molecular Design of Pharmaceutics,Faculty of Pharmaceutical Sciences,Hokkaido University,Sapporo,Japan;Laboratory of Innovative Nanomedicine,Faculty of Pharmaceutical Sciences,Hokkaido University,Sapporo,Japan
引用格式:
[1]Seigo Kimura-.Non-invasive gene delivery across the blood-brain barrier: present and future perspectives)[J].中国神经再生研究(英文版),2022(04):785-787
A类:
Feigin,givers
B类:
Non,invasive,delivery,across,blood,brain,barrier,present,future,perspectives,aging,society,has,arrived,accompanied,by,increase,absolute,numbers,patients,neurological,disorders,such,Alzheimer,Parkinson,diseases,Such,particularly,other,forms,dementia,affect,not,only,themselves,but,also,people,around,including,family,members,care,result,thought,carry,larger,social,burden,compared,most,critical,point,current,situation,that,there,effective,treatment,despite,fact,population,Gene,therapy,great,promise,Sun,Roy,delivering,therapeutic,genes,major,impediment,success
AB值:
0.60067
相似文献
Deletion of CHD8 in cerebellar granule neuron progenitors leads to severe cerebellar hypoplasia,ataxia,and psychiatric behavior in mice
Xiang Chen;Tong Chen;Chen Dong;Huiyao Chen;Xinran Dong;Lin Yang;Liyuan Hu;Huijun Wang;Bingbing Wu;Ye Yao;Yu Xiong;Man Xiong;Yifeng Lin;Wenhao Zhou-Departments of Neonatology,Children's Hospital of Fudan University,National Children's Medical Center,Shanghai 201102,China;Institutes of Biomedical Sciences,Fudan University,Shanghai 200032,China;Key Laboratory of Birth Defects,Children's Hospital of Fudan University,National Children's Medical Center,Shanghai 201102,China;Department of Biostatistics,School of Public Health,Fudan University,Shanghai 200032,China;Department of Obstetrics,Obstetrics and Gynecology Hospital of Fudan University,Shanghai 200090,China;Stem Cell Center,Children's Hospital of Fudan University,Shanghai 201102,China;MOE Frontiers Center for Brain Science,Fudan University,Shanghai 201102,China
Patients with breath test positive are necessary to be identified from irritable bowel syndrome: a clinical trial based on microbiomics and rifaximin sensitivity
Liu Zuojing;Zhu Shiwei;He Meibo;Li Mo;Wei Hui;Zhang Lu;Sun Qinghua;Jia Qiong;Hu Nan;Fang Yuan;Song Lijin;Zhou Chen;Tao Heqing;Y Kao John;Zhu Huaiqiu;Owyang Chung;Duan Liping-Department of Gastroenterology, Peking University Third Hospital, Haidian District, Beijing 100191, China;Department of Ultrasound, Peking University Third Hospital, Haidian District, Beijing 100191, China;Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China;Department of Biomedical Engineering, College of Engineering, Peking University, Beijing 100187, China;Division of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, 6520 MSRB I, SPC 5682, 1150 West Medical Center Drive, Ann Arbor, MI 48109, USA
Alzheimer's disease:current status and perspective
Wenying Liu;Serge Gauthier;Jianping Jia-Innovation Center for Neurological Disorders and Department of Neurology,Xuanwu Hospital,Capital Medical University,National Clinical Research Center for Geriatric Diseases,Beijing 100053,China;Departments of Neurology and Neurosurgery,and Department of Psychiatry,McGill Centre for Studies in Aging,McGill University,Montreal H4H1R3,Canada;Beijing Key Laboratory of Geriatric Cognitive Disorders,Beijing 100053,China;Clinical Center for Neurodegenerative Disease and Memory Impairment,Capital Medical University,Beijing 100053,China;Center of Alzheimer's Disease,Beijing Institute of Brain Disorders,Collaborative Innovation Center for Brain Disorders,Capital Medical University,Beijing 100053,China;Key Laboratory of Neurodegenerative Diseases,Ministry of Education,Beijing 100053,China
Structural basis of the activation of metabotropic glutamate receptor 3
Wei Fang;Fan Yang;Chanjuan Xu;Shenglong Ling;Li Lin;Yingxin Zhou;Wenjing Sun;Xiaomei Wang;Peng Liu;Philippe Rondard;Pan Shi;Jean-Philippe Pin;Changlin Tian;Jianfeng Liu-The First Affiliated Hospital of USTC,School of Life Sciences,Division of Life Sciences and Medicine,Joint Center for Biological Analytical Chemistry,Anhui Engineering Laboratory of Peptide Drug,Anhui Laboratory of Advanced Photonic Science and Technology,University of Science and Technology of China,Hefei,Anhui,China;Key Laboratory of Molecular Biophysics of MOE,International Research Center for Sensory Biology and Technology of MOST,College of Life Science and Technology,Huazhong University of Science and Technology(HUST),Wuhan,Hubei,China;Bioland Laboratory,Guangzhou Regenerative Medicine and Health Guangdong Laboratory,Guangzhou,Guangdong,China;Institut de Génomique Fonctionnelle(IGF),Université de Montpellier,CNRS,INSERM,Montpellier,France
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment
Da-cai Xu;Li Yang;Pei-quan Zhang;Ding Yan;Qian Xue;Qing-tian Huang;Xiao-fen Li;Ya-li Hao;Dao-lin Tang;Q.Ping Dou;Xin Chen;Jin-bao Liu-Affliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;The Department of Physiology,School of Basic Medical Sciences,Guizhou Medical University,Guiyang 550003,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。